title: Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization.
authors.affiliation: Department of Cell and Developmental Biology, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel. ; Alexander Grass Center for Bioengineering, Hebrew University of Jerusalem, Jerusalem, Israel.
authors.forename: Triana
authors.initials: T
authors.lastname: Amen
authors.affiliation: Department of Cell and Developmental Biology, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel.
authors.forename: Daniel
authors.initials: D
authors.lastname: Kaganovich
keywords: Alzheimer’s; FDA; amyloid beta; drug; screen; yeast